Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Helse- & Idrætsklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   3.7% 7.3% 7.7% 9.3% 6.3% 8.3% 11.7% 11.7%   Credit score (0-100)   53 34 31 25 37 28 21 21   Credit rating   BBB BBB BB BB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   331 173 197 117 100 192 0.0 0.0   EBITDA   322 50.3 -70.9 -67.1 59.4 -51.7 0.0 0.0   EBIT   222 -49.7 -171 -167 12.7 -91.7 0.0 0.0   Pre-tax profit (PTP)   191.8 -66.6 -178.5 -175.3 6.3 -97.9 0.0 0.0   Net earnings   149.7 -45.1 -147.8 -131.9 3.0 -102.0 0.0 0.0   Pre-tax profit without non-rec. items   192 -66.6 -179 -175 6.3 -97.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   66.7 46.7 26.7 6.6 0.0 40.8 0.0 0.0   Shareholders equity total   240 195 -27.5 -120 -117 -219 -263 -263   Interest-bearing liabilities   587 417 662 595 501 569 610 610   Balance sheet total (assets)   907 641 709 513 451 432 347 347   Net Debt   503 412 660 593 496 542 610 610     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   331 173 197 117 100 192 0.0 0.0   Gross profit growth   48.7% -47.7% 13.5% -40.4% -14.6% 91.3% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   907 641 709 513 451 432 347 347   Balance sheet change%   -11.6% -29.3% 10.5% -27.6% -12.1% -4.2% -19.8% 0.0%   Added value   321.7 50.3 -70.9 -67.1 112.7 -51.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -200 -200 -200 -200 -93 -39 -41 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 -3.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   67.0% -28.7% -86.9% -142.5% 12.7% -47.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.9% -6.4% -24.8% -24.4% 2.1% -15.0% 0.0% 0.0%   ROI %   23.9% -6.8% -26.4% -26.0% 2.2% -15.9% 0.0% 0.0%   ROE %   90.5% -20.7% -32.7% -21.6% 0.6% -23.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.8% 31.3% -3.8% -19.0% -20.9% -33.7% -43.2% -43.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   156.3% 818.3% -932.1% -883.6% 835.0% -1,048.0% 0.0% 0.0%   Gearing %   244.4% 213.8% -2,403.3% -493.6% -426.7% -259.4% -231.6% -231.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.0% 3.4% 1.4% 1.3% 1.2% 1.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0   Cash and cash equivalent   84.5 5.4 1.6 1.6 5.1 27.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -238.1 -433.8 -658.1 -578.3 -469.1 -559.3 -305.0 -305.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -52 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -52 0 0   EBIT / employee   0 0 0 0 0 -92 0 0   Net earnings / employee   0 0 0 0 0 -102 0 0